key: cord-0922623-lhri0uyr
authors: Schultz, Marcus J.; Sivakorn, Chaisith; Dondorp, Arjen M.
title: Challenges and Opportunities for Lung Ultrasound in Novel Coronavirus Disease (COVID-19)
date: 2020-04-24
journal: Am J Trop Med Hyg
DOI: 10.4269/ajtmh.20-0323
sha: 58197022bcd3946b401bc10fa66bfaf6fb226fae
doc_id: 922623
cord_uid: lhri0uyr

Challenges and Opportunities for Lung Ultrasound in Novel Coronavirus Disease (COVID-19).

Journal of Tropical Medicine and Hygiene, Yasukawa and Taro 6 report their first experience with LUS in a case series of COVID-19 patients in the United States. All patients had "comet tails" (or "glass rockets"), with or without a "white lung" ("Birolleau variant"), and confluent B lines. Irregular pleural lines were also present in all patients, and half of the patients had small subpleural consolidations. In the one patient with a concomitant chest CT scan, peripheral opacification on the CT scan matched with a white lung area on the LUS images.

The good sensitivity of bedside LUS to detect lung lesions in COVID-19 makes this an attractive additional diagnostic tool in patients suspected of COVID-19, often nursed in isolation rooms or on isolation wards. Lung ultrasound has been implemented for this purpose in several COVID-19-designated hospitals in Thailand. These centers are now also gaining experience in performing daily LUS for early detection of disease progression in COVID-19, with results important for decisions on escalation of care. 7 One challenge with LUS is defining consistent systems for reporting and interpretation of findings. One frequently used approach is semi-quantification of lung aeration across 12 lung regions into a numerical "global score," in which the presence of A lines counts as "0," less or more B lines count as "1" or "2," and consolidation counts as "3." 8 Scores are then summed to a global score that ranges from 0 (i.e., "no abnormalities at all") to 36 (i.e., "consolidations in all regions"). Global LUS scores combined with SpO 2 /FiO 2 in a resourcelimited setting, 9 and with PaO 2 /FiO 2 in a resource-rich setting, 10 showed good performance for diagnosing acute respiratory distress syndrome (ARDS) and for assessing ARDS severity. 11 Of note, current global LUS scores do not include pleural thickening and subpleural abnormalities, which seem often present in COVID-19. We should evaluate urgently whether a global LUS score has diagnostic and prognostic value in COVID-19, whether scores correlate with disease severity and CT findings, and how pleural thickening and subpleural abnormalities should be incorporated in the scoring system.

Lung ultrasound could potentially also be an important tool for optimizing invasive ventilation in patients with severe COVID-19. 12 Although patients with COVID-19 receiving invasive ventilation will often have non-recruitable lung lesions early on, recruitable lesions may develop later in the disease course. In patients with lung lesions that can be opened up, recruitment maneuvers and higher positive end-expiratory pressure (PEEP) may be beneficial. 13 It is currently not well defined how these recruitable lung areas can be best identified. Comparing the same lung lesion on chest CT scan at different PEEP levels (10 and 20 cm H 2 O) can show whether a lesion becomes aerated (Schultz, personal experience in Amsterdam). However, this procedure is impractical, especially in resource-limited settings. In patients with ARDS, it has been shown that PEEP-induced lung recruitment can be adequately estimated with bedside LUS. 14 A study to assess LUS as a tool to detect recruitable lung lesions in patients with severe COVID-19 is currently underway in Amsterdam, the Netherlands, and Brussels, Belgium.

In summary, the report from Yasukawa and Taro 6 shows that LUS is a promising additional lung imaging tool in COVID-19, in particular in settings with limited resources. This easyto-perform bedside tool could prove to be important in diagnosis, prognostication, and follow-up of patients, and might also enable identification of recruitable lung lesions to guide invasive ventilation.

The role of chest imaging in patient management during the COVID-19 pandemic: a multinational consensus statement from the Fleischner Society

Performance of radiologists in differentiating COVID-19 from viral pneumonia on chest CT

Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients

Case report: walking pneumonia in novel coronavirus disease (COVID-19): mild symptoms with marked abnormalities on chest imaging

COVID-19 CORADS Classification

Point-of-care lung ultrasound findings in patients with COVID-19 pneumonia

Guidelines for Health Care and Public Health Workers

International evidencebased recommendations for point-of-care lung ultrasound

Hospital Incidence and outcomes of the acute respiratory distress syndrome using the Kigali modification of the Berlin definition

External confirmation and exploration of the Kigali modification for diagnosing moderate or severe ARDS

The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores -a post hoc analysis of an observational study in invasively ventilated ICU patients

Respiratory support in COVID-19 patients, with a focus on resource-limited settings

High vs low PEEP in nonrecruitable collapsed lung tissue: possible implications for patients with COVID-19

Bedside ultrasound assessment of positive endexpiratory pressure-induced lung recruitment